Changes in Sexist Beliefs and Psychological Flexibility Among Men Court-Mandated to Domestic Violence Programs.

J Interpers ViolenceSep 24, 2025 (epub)
Clinical ResearchPsychiatry

Amie Zarling, Meg Berta, Carl F Weems

✦ AI-curated · Sources linked

In 30 seconds

This randomized controlled trial examined changes in self-reported psychological flexibility and sexist beliefs among 84 men attending court-mandated domestic violence programs based on acceptance and commitment therapy (ACT) or the Duluth Model. Both interventions were associated with improvements in both measures from pre- to post-treatment. ACT participants showed a stronger association between psychological flexibility and reduced sexism. Men who did not re-offend had significant changes in both processes, whereas those who re-offended showed no significant change. The abstract does not report effect sizes or recidivism rates.

Key findings

  • Both ACT- and Duluth-based programs were associated with improvements in psychological flexibility and sexist beliefs.
  • In the ACT group, psychological flexibility had a stronger association with reduced sexism.
  • Men who did not re-offend showed significant changes in psychological flexibility and sexism; those who re-offended showed no significant change.

Why it matters

The findings offer evidence about processes that may accompany change during batterer intervention programs, rather than focusing only on outcomes. The differing pattern by re-offending status may help inform research into how psychological flexibility and sexist beliefs relate to program response, while not establishing that changes in these measures prevent re-offending.

What to keep in mind

The study assessed self-reported pre- to post-treatment changes in 84 men; the abstract provides no effect sizes or details on follow-up duration.

Source

Published in J Interpers Violence. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Psychiatry

Clinical ResearchOncology (Medical)

Zamtocabtagene autoleucel, a tandem CD20-CD19-directed CAR T-cell therapy, for second line treatment of large B-cell lymphoma in patients ineligible for transplantation (DALY 2-EU): primary analysis of an open-label, multicentre, randomised phase 2 study.

DALY 2-EU was an open-label, multicentre, randomised phase 2 trial comparing tandem CD20-CD19-directed zamtocabtagene autoleucel (zamto-cel) with R-GemOx in adults with second-line relapsed or refractory large B-cell…

Lancet OncolOct 27, 2026Read summary
Clinical ResearchOncology (Medical)

Neoadjuvant short-course radiotherapy followed by camrelizumab and chemotherapy versus standard of care for locally advanced rectal cancer (UNION): a prespecified interim analysis of a multicentre, open-label, randomised, phase 3 trial.

UNION was a multicentre, open-label, randomised phase 3 trial at nine hospitals in China comparing neoadjuvant short-course radiotherapy followed by camrelizumab plus CAPOX with long-course chemoradiotherapy followed by…

Lancet OncolOct 25, 2026Read summary
Clinical ResearchHematology

Efficacy and safety of mitapivat in patients with sickle cell disease (RISE UP): a phase 3, double-blind, global, randomised, placebo-controlled trial.

RISE UP was a phase 3, double-blind, global, randomised, placebo-controlled trial conducted at 69 sites in 15 countries. It evaluated twice-daily mitapivat in patients older than 16 years with sickle cell disease…

LancetOct 24, 2026Read summary

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.